Heterocyclic compound

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9890145
SERIAL NO

15137161

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a heterocyclic compound having an IRAK-4 inhibitory action, which is useful for the prophylaxis or treatment of inflammatory disease, autoimmune disease, osteoarticular degenerative disease, neoplastic disease and the like, and a medicament containing thereof. The present invention relates to a compound represented by the formula (I):

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • TAKEDA PHARMACEUTICAL COMPANY LIMITED

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gibson, Tony San Diego, US 5 89
Sasaki, Yusuke Kanagawa, JP 85 668
Shibuya, Akito Kanagawa, JP 13 50
Shiokawa, Zenyu Kanagawa, JP 13 69
Takagi, Terufumi Kanagawa, JP 15 126
Takami, Kazuaki Kanagawa, JP 25 53
Tominari, Yusuke Kanagawa, JP 15 91
Yoshida, Masato Kanagawa, JP 210 2932

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 13, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 13, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00